Kerusso Capital Management LLC has filed a Form 13F-HR with the U.S. Securities and Exchange Commission, disclosing its equity holdings as of September 30, 2026. The filing, signed by Chief Administrative Officer Shannon Barnes, lists 59 separate positions held by the firm.
The report details a portfolio valued at approximately $306.2 million. The largest holding in the portfolio is 3M Company, for which Kerusso Capital holds 6,114,752 shares, representing a value of $37.3 million. Other significant positions include Apple Inc., with 10,738,563 shares valued at $32.2 million, and AbbVie Inc., with 6,483,770 shares valued at $24.8 million.
The filing includes a diverse mix of technology, healthcare, and consumer goods companies. Major technology names listed in the report include NVIDIA Corporation, with 7,724,725 shares valued at $33.8 million; Microsoft Corporation, with 8,231,170 shares valued at $77.3 million; and Adobe Inc., with 4,845,108 shares valued at $20.2 million. In the healthcare sector, the firm holds significant positions in Gilead Sciences, Inc., with 8,272,871 shares valued at $55.5 million, and Merck & Co., Inc., with 4,368,745 shares valued at $30.1 million.
The filing also lists positions in industrial and financial sectors, such as Caterpillar Inc., with 3,428,831 shares valued at $4.2 million, and Verizon Communications Inc., with 5,331,516 shares valued at $11.6 million. Additionally, the report includes exchange-traded funds, such as the iShares MSCI ACWI ex US ETF and the SPDR S&P 500 ETF Trust.
